The feasibility and acceptability of home phlebotomy for patients with cancer
JNCI Cancer Spectrum · 01.11.2024 · 8 (6)
DOI: 10.1093/jncics/pkae104 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 16.10.2024. Verfasst von Erin M Bange und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, United States. Hauptthemen laut MEDLINE: Phlebotomy, Neoplasms, Feasibility Studies, Patient Satisfaction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, Memorial Sloan Kettering Cancer Center.
Abstract (Originalsprache)
Time toxicity is a considerable burden for oncology patients. This study evaluated the feasibility and acceptability of integrating mobile phlebotomy into standard of care procedures. From September 26, 2022, through December 31, 2023, a total of 345 patients had 1464 home laboratory test collection visits completed. These mobile phlebotomy laboratory collection visits occurred in New York (68.6% of visits), New Jersey (29.9%), Connecticut (1.1%), and Pennsylvania (0.5%). Specimen quality for home laboratory test collection surpassed the Memorial Sloan Kettering Department of Pathology and Laboratory Medicine benchmarks. Acceptability was high, 173 patients were approached, and 149 responded (86% response rate); most respondents (147 of 149, 99%) would use the service again or recommend it to others. This study assessed the integration of mobile phlebotomy into standard of care management for the collection of routine cancer laboratory tests. Mobile phlebotomy results in high patient satisfaction with superior specimen quality, offering a valuable solution to oncology patients for improved efficiency and convenience.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, United States.
ORCID-Profile: Erin M Bange, Camila Bernal, Bobby Daly
Förderung
- NCI NIH HHS
- National Cancer Institute
- Memorial Sloan Kettering Cancer Center
Zitieren
APA
Bange, E. M., Bernal, C., Gaffney, K. B., Ackerman, J., Kwong, D., Thomas, J., & Daly, B. (2024). The feasibility and acceptability of home phlebotomy for patients with cancer. JNCI Cancer Spectrum, 8(6). https://doi.org/10.1093/jncics/pkae104
Vancouver
Bange EM, Bernal C, Gaffney KB, Ackerman J, Kwong D, Thomas J, et al. The feasibility and acceptability of home phlebotomy for patients with cancer. JNCI Cancer Spectrum. 2024;8(6). doi:10.1093/jncics/pkae104
BibTeX
@article{Bange2024,
author = {Bange, Erin M and Bernal, Camila and Gaffney, Kemi Bolutayo and Ackerman, Jill and Kwong, David and Thomas, Jithin and Daly, Bobby},
title = {The feasibility and acceptability of home phlebotomy for patients with cancer},
journal = {JNCI Cancer Spectrum},
year = {2024},
volume = {8},
number = {6},
doi = {10.1093/jncics/pkae104}
}
EUVIMED